353280-43-0 Usage
Uses
Used in Pharmaceutical Industry:
[[4-[2-(6-Benzoyl-2-oxo-3(2H)-benzothiazolyl)ethoxy]phenyl]methyl]-1,3-propanedioic acid dimethyl ester is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure may provide specific biological activities, making it a valuable building block in the development of new drugs.
Used in Chemical Research:
In the field of chemical research, [[4-[2-(6-Benzoyl-2-oxo-3(2H)-benzothiazolyl)ethoxy]phenyl]methyl]-1,3-propanedioicaciddimethylester can be utilized as a research tool to study the properties and reactivity of benzothiazole-based molecules. It may also be employed in the development of new synthetic methods or as a reference material for comparative studies.
Used in Material Science:
[[4-[2-(6-Benzoyl-2-oxo-3(2H)-benzothiazolyl)ethoxy]phenyl]methyl]-1,3-propanedioicaciddimethylester's specific chemical and physical properties may make it suitable for use in the development of new materials with tailored properties. It could potentially be incorporated into the design of advanced materials for various applications, such as sensors, optoelectronics, or coatings.
Used in Dye and Pigment Industry:
Given its complex structure and potential for chromophore formation, [[4-[2-(6-Benzoyl-2-oxo-3(2H)-benzothiazolyl)ethoxy]phenyl]methyl]-1,3-propanedioic acid dimethyl ester may find applications in the dye and pigment industry as a colorant or as a precursor for the synthesis of novel dyes and pigments.
Check Digit Verification of cas no
The CAS Registry Mumber 353280-43-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,3,2,8 and 0 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 353280-43:
(8*3)+(7*5)+(6*3)+(5*2)+(4*8)+(3*0)+(2*4)+(1*3)=130
130 % 10 = 0
So 353280-43-0 is a valid CAS Registry Number.
353280-43-0Relevant academic research and scientific papers
Novel 1,3-dicarbonyl compounds having 2(3H)-benzazolonic heterocycles as PPARγ agonists
Blanc-Delmas, Elodie,Lebegue, Nicolas,Wallez, Valerie,Leclerc, Veronique,Yous, Said,Carato, Pascal,Farce, Amaury,Bennejean, Caroline,Renard, Pierre,Caignard, Daniel-Henri,Audinot-Bouchez, Valerie,Chomarat, Pascale,Boutin, Jean,Hennuyer, Nathalie,Louche, Katie,Carmona, Maria Carmen,Staels, Bart,Penicaud, Luc,Casteilla, Louis,Lonchampt, Michel,Dacquet, Catherine,Chavatte, Philippe,Berthelot, Pascal,Lesieur, Daniel
, p. 7377 - 7391 (2007/10/03)
A series of 1,3-dicarbonyl compounds having 2(3H)-benzazolonic heterocycles has been synthesized and tested for PPARγ agonist activity. SAR were developed and revealed that 6-acyl-2(3H)-benzothiazolone derivatives with 1,3-dicarbonyl group were the most potent. IP administration of compound 22 exhibited comparable levels of glucose and triglyceride correction to PO administration of rosiglitazone in the ob/ob mouse studies.
Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
-
, (2008/06/13)
Compounds of formula (I): wherein: X represents an oxygen atom or a sulphur atom or a group CH2 or R1 and R2 represent a hydrogen atom, or a group as defined in the description, A represents an alkylene chain as described
